Cardiologist questions cholesterol drugs for heart health, says chasing numbers may not address the ‘root cause’

Cholesterol-lowering medications are widely used to reduce the risk of heart disease and other cardiovascular complications. Cardiologist Dr Jack Wolfson has questioned the extent of their benefits, urging people to look beyond medication and address what he describes as the “root cause” of heart disease. (Also read: Want to know how healthy your heart is? Cardiologist Dr Sanjay Bhojraj lists 9 blood tests for ‘cardiovascular risk )

A major cardiovascular study published in April 2026 has sparked discussion over the benefits of further lowering cholesterol to reduce the risk of heart-related complications. The VESALIUS-CV trial , published in The New England Journal of Medicine, studied more than 12,000 high-risk participants who had not previously suffered a heart attack or stroke and followed them for a median of 4.6 years.

The study found that adding a cholesterol-lowering treatment to standard therapy reduced the risk of major cardiovascular events compared with placebo.

In an August 31 Instagram video, Dr Wolfson discussed the trial’s reported number needed to treat, a measure used to estimate how many people need to receive a treatment for one additional person to benefit.

“All right, you're probably wondering why this number here says 56. Well, 56 is the late-breaking number needed to treat according to the Vesalius trial,” he said. He claimed that 56 people would need to receive the cholesterol-lowering treatment instead of a placebo for more than four and a half years to prevent one death.

A post shared by Dr. Jack Wolfson / Cardiologist Natural Heart Doctor (@natural_heart_doctor)

Dr Wolfson questioned the extent of the benefit associated with the treatment and argued that patients may already be taking other medications to manage cholesterol and cardiovascular risk. “This is in addition to all the other drugs that they have you on, the statin drugs, drugs like ezetimibe,” he said.

He went on to describe the benefit as “trivial” and claimed that lowering LDL cholesterol to very low levels through medication was not a long-term strategy for health and wellness.

The cardiologist also criticised what he described as an over-reliance on pharmaceutical treatments in conventional cardiology. “You need to pull yourself out of the medical matrix,” he said. He also referred to some of his former cardiology colleagues as “glorified pharmaceutical reps” and urged viewers to seek what he called “root cause cardiology”.

Explaining his “root cause cardiology” approach, Dr Wolfson argued that cardiovascular health should be viewed beyond cholesterol numbers and medication.